<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-156773</identifier>
<setSpec>0211-139X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Pharmacological treatment</dc:title>
<dc:description xml:lang="en">Alzheimer&#146;s disease (AD) is a chronic degenerative and inflammatory process leading to synaptic dysfunction and neuronal death. A review about the pharmacological treatment alternatives is made: acetylcholinesterase inhibitors (AChEI), a nutritional supplement (Souvenaid) and Ginkgo biloba. A special emphasis on Ginkgo biloba due to the controversy about its use and the approval by the European Medicines Agency is made (AU)</dc:description>
<dc:creator>Arriola Manchola, Enrique</dc:creator>
<dc:creator>Álaba Trueba, Javier</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La enfermedad de Alzheimer es un proceso degenerativo e inflamatorio crónico que conduce a una disfunción sináptica y a la muerte neuronal. Se realiza una revisión sobre las alternativas terapéuticas farmacológicas: los inhibidores de la acetilcolinesterasa, la memantina, un suplemento alimenticio: Souvenaid y la Ginkgo biloba. Se hace un especial hincapié en la Ginkgo biloba dadas las controversias sobre su uso y la aprobación por parte de la European Medicines Agency (AU)</dc:description>
<dc:source>Rev. esp. geriatr. gerontol. (Ed. impr.);51(supl.1): 22-26, jun. 2016. tab</dc:source>
<dc:identifier>ibc-156773</dc:identifier>
<dc:title xml:lang="es">Terapias farmacológicas</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d4418^s22074</dc:subject>
<dc:subject>^d545^s22057</dc:subject>
<dc:subject>^d4418^s22045</dc:subject>
<dc:subject>^d33751</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24240^s22073</dc:subject>
<dc:subject>^d2850^s22044</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d4418^s22039</dc:subject>
<dc:subject>^d2850^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201606</dc:date>
</metadata>
</record>
</ibecs-document>
